My best ASX 200 shares to buy in January

There is a lot to like about these ASX 200 shares. Here's why they could be best buys.

| More on:
A man holding a cup of coffee puts his thumb up and smiles while at laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL remains a dominant force in the global blood plasma market despite disappointing in 2025, with short-term headwinds like margin pressures and weak flu vaccine sales creating a potential buying opportunity for patient investors willing to look past temporary setbacks.
  • Macquarie's diversified earnings across asset management, infrastructure, and capital markets help smooth returns through economic cycles, with its global expertise positioning it well for long-term investment trends despite some recent underperformance.
  • Woolworths' shares have fallen meaningfully from their highs, but the supermarket giant's ongoing investments in automation and digital capability could pay off as margin pressures ease and the competitive environment stabilises.

A new year often brings fresh optimism for investors, and January can be a great time to revisit an investment portfolio.

But which ASX 200 shares could be great picks for investors right now?

Let's take a look at three that I think are among the best to buy this month and for 2026:

CSL Ltd (ASX: CSL)

It may have disappointed in 2025, but CSL remains one of the highest-quality companies on the Australian share market. The global biotech leader dominates the blood plasma market and has a deep pipeline of therapies that should be supportive of long-term earnings growth.

Short-term issues, including margin pressures, albumin demand, and weak influenza vaccine sales, have weighed on sentiment. But these factors don't change the core investment case. Demand for plasma therapies continues to grow globally, barriers to entry are extremely high, and CSL's scale gives it a significant competitive advantage.

For patient investors, January could be an attractive time to accumulate shares while the market remains cautious, rather than chasing the stock once momentum returns.

Macquarie Group Ltd (ASX: MQG)

Macquarie is Australia's leading global investment bank. Its earnings are diversified across asset management, infrastructure, commodities, and capital markets. This helps smooth returns across economic cycles.

While there has been underperformance in parts of its business in FY 2026, I don't expect this to be for long. Macquarie has a long history of adapting to changing conditions. Its asset management division continues to grow funds under management, while its infrastructure expertise positions it well for long-term global investment trends.

For investors looking for an ASX 200 share with exposure well beyond the domestic economy, Macquarie remains a high-quality option to consider early in the year.

Woolworths Group Ltd (ASX: WOW)

Woolworths may not be the most exciting stock on the market, but its reliability is exactly what makes it appealing. As one of Australia's dominant supermarket operators, it generates steady cash flow regardless of economic conditions.

Margin pressure and increased competition have been weighing on its performance over the past 12 months, but there are signs that the worst is now behind it. In addition, during this time Woolworths has continued to invest heavily in automation, supply chain efficiency, and digital capability. Over time, I believe these investments will bear fruit and position it for the future.

For investors building a balanced ASX 200 portfolio, Woolworths offers defensive characteristics that can complement higher-growth holdings. And with its shares down meaningfully from their highs, now could be an opportune time to load up on them.

Motley Fool contributor James Mickleboro has positions in CSL and Woolworths Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group and Woolworths Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Two elderly men laugh together as they take a selfie with a mobile phone with a city scape in the background.
Blue Chip Shares

The ASX 200 stocks I'd be happy to hold until retirement

I think some shares stand out as great long term holds.

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Blue Chip Shares

3 ASX 200 blue-chip shares I would buy with $100,000

If I had $100,000 to invest today, I’d back proven blue chips built to endure and compound through market cycles.

Read more »

A woman sits on sofa pondering a question.
Blue Chip Shares

3 no-brainer ASX stocks to buy with $1,000 right now for the New Year

You don’t need to overthink it. Here are three no-brainer ASX stocks to buy as the New Year begins.

Read more »

A woman standing in a blue shirt smiles as she uses her mobile phone.
Blue Chip Shares

Why I think Telstra and Woolworths shares are buys for passive income

Boring can be beautiful. Here’s why Telstra and Woolworths stand out as passive income shares.

Read more »

Two older men in suits walk down the street in the sunlight, one congenially rests his hand on the other's shoulder.
Blue Chip Shares

Decade darlings – these ASX shares have provided 10 years of returns

These stocks have stood the test of time.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Blue Chip Shares

Here are my top 3 ASX shares to buy in January

These 3 ASX 200 shares look oversold after recent weakness and could offer attractive entry points this month.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Blue Chip Shares

3 Australian shares with bullish catalysts heading into 2026

Not all ASX shares are equal in 2026. These three have catalysts that could move the needle.

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Blue Chip Shares

Where to invest $10,000 into ASX 200 shares in January 2026

Brokers think these shares are top picks for investors next month.

Read more »